EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Withus Pharmaceutical Co's enterprise value is ₩107,149 Mil.
Withus Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ₩102,506 Mil. Therefore, Withus Pharmaceutical Co's EV-to-Revenue for today is 1.05.
The historical rank and industry rank for Withus Pharmaceutical Co's EV-to-Revenue or its related term are showing as below:
XKRX:330350'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.82 Med: 1.66 Max: 10.37
Current: 1.04
During the past 6 years, the highest EV-to-Revenue of Withus Pharmaceutical Co was 10.37. The lowest was 0.82. And the median was 1.66.
XKRX:330350's EV-to-Revenue is ranked better than 78.83% of 973
companies
in the Drug Manufacturers industry
Industry Median: 2.43
vs XKRX:330350: 1.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Withus Pharmaceutical Co's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Withus Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Withus Pharmaceutical Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Withus Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Withus Pharmaceutical Co's EV-to-Revenue falls into.
Withus Pharmaceutical Co's current Enterprise Value is ₩107,149 Mil.
Withus Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩102,506 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Withus Pharmaceutical Co (XKRX:330350) EV-to-Revenue Explanation
Withus Pharmaceutical Co's share price for today is ₩7870.00.
Withus Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩7,788.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Withus Pharmaceutical Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Withus Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Withus Pharmaceutical Co Ltd is a pharmaceutical company. The firm is engaged in the manufacturing and selling of various medicines such as Broazette long-acting tablet, Wipina tablets, Mantini tablets, and Choline syrup among others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:330350 has been successfully added to your 